GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » EV-to-Revenue

Boule Diagnostics AB (OSTO:BOUL) EV-to-Revenue : 0.92 (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Boule Diagnostics AB's enterprise value is kr529.7 Mil. Boule Diagnostics AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr576.2 Mil. Therefore, Boule Diagnostics AB's EV-to-Revenue for today is 0.92.

The historical rank and industry rank for Boule Diagnostics AB's EV-to-Revenue or its related term are showing as below:

OSTO:BOUL' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.68   Med: 1.99   Max: 4.67
Current: 0.92

During the past 13 years, the highest EV-to-Revenue of Boule Diagnostics AB was 4.67. The lowest was 0.68. And the median was 1.99.

OSTO:BOUL's EV-to-Revenue is ranked better than
85.56% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.26 vs OSTO:BOUL: 0.92

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Boule Diagnostics AB's stock price is kr10.10. Boule Diagnostics AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr14.87. Therefore, Boule Diagnostics AB's PS Ratio for today is 0.68.


Boule Diagnostics AB EV-to-Revenue Historical Data

The historical data trend for Boule Diagnostics AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB EV-to-Revenue Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.92 3.12 2.30 1.24 0.99

Boule Diagnostics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 1.00 0.87 0.99 0.91

Competitive Comparison of Boule Diagnostics AB's EV-to-Revenue

For the Medical Devices subindustry, Boule Diagnostics AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's EV-to-Revenue falls into.



Boule Diagnostics AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Boule Diagnostics AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=529.714/576.229
=0.92

Boule Diagnostics AB's current Enterprise Value is kr529.7 Mil.
Boule Diagnostics AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr576.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boule Diagnostics AB  (OSTO:BOUL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Boule Diagnostics AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=10.10/14.869
=0.68

Boule Diagnostics AB's share price for today is kr10.10.
Boule Diagnostics AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr14.87.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boule Diagnostics AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB (OSTO:BOUL) Business Description

Traded in Other Exchanges
N/A
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB (OSTO:BOUL) Headlines

No Headlines